JP2023020885A5 - - Google Patents

Download PDF

Info

Publication number
JP2023020885A5
JP2023020885A5 JP2022083287A JP2022083287A JP2023020885A5 JP 2023020885 A5 JP2023020885 A5 JP 2023020885A5 JP 2022083287 A JP2022083287 A JP 2022083287A JP 2022083287 A JP2022083287 A JP 2022083287A JP 2023020885 A5 JP2023020885 A5 JP 2023020885A5
Authority
JP
Japan
Prior art keywords
free form
difelikephalin
dry weight
injection
administer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022083287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023020885A (ja
Filing date
Publication date
Priority claimed from JP2021123323A external-priority patent/JP7430669B2/ja
Application filed filed Critical
Priority to JP2022083287A priority Critical patent/JP2023020885A/ja
Publication of JP2023020885A publication Critical patent/JP2023020885A/ja
Publication of JP2023020885A5 publication Critical patent/JP2023020885A5/ja
Pending legal-status Critical Current

Links

JP2022083287A 2021-07-28 2022-05-20 透析患者に適用される注射用医薬組成物 Pending JP2023020885A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022083287A JP2023020885A (ja) 2021-07-28 2022-05-20 透析患者に適用される注射用医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021123323A JP7430669B2 (ja) 2021-07-28 2021-07-28 透析患者に適用される注射用医薬組成物
JP2022083287A JP2023020885A (ja) 2021-07-28 2022-05-20 透析患者に適用される注射用医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021123323A Division JP7430669B2 (ja) 2021-07-28 2021-07-28 透析患者に適用される注射用医薬組成物

Publications (2)

Publication Number Publication Date
JP2023020885A JP2023020885A (ja) 2023-02-09
JP2023020885A5 true JP2023020885A5 (enExample) 2025-03-03

Family

ID=85160512

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021123323A Active JP7430669B2 (ja) 2021-07-28 2021-07-28 透析患者に適用される注射用医薬組成物
JP2022083287A Pending JP2023020885A (ja) 2021-07-28 2022-05-20 透析患者に適用される注射用医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021123323A Active JP7430669B2 (ja) 2021-07-28 2021-07-28 透析患者に適用される注射用医薬組成物

Country Status (1)

Country Link
JP (2) JP7430669B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7430669B2 (ja) * 2021-07-28 2024-02-13 キッセイ薬品工業株式会社 透析患者に適用される注射用医薬組成物
CN120131905B (zh) * 2025-03-06 2025-08-29 苏州天马医药集团天吉生物制药有限公司 一种提高醋酸地非法林制剂稳定性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1909790A4 (en) 2005-07-12 2009-07-29 Eisai Corp North America METHODS FOR ASSAYING PROPOFOL PRODRUGS TO INDUCE LIGHT TO MODERATE SEDATION LEVELS
JP7430669B2 (ja) * 2021-07-28 2024-02-13 キッセイ薬品工業株式会社 透析患者に適用される注射用医薬組成物

Similar Documents

Publication Publication Date Title
KR20250090374A (ko) Gip/glp1 작용제 조성물
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
EP2635269B1 (en) A combination composition
JP2023166388A5 (enExample)
JP2005501110A5 (enExample)
JP2023020885A5 (enExample)
JP2017533972A5 (enExample)
JP2018531605A5 (enExample)
JP2020510043A5 (enExample)
US11963940B2 (en) Parenteral esmolol formulation
JP2007508284A5 (enExample)
JP2012533542A5 (enExample)
JP2014502608A5 (enExample)
JP2022089867A (ja) 安定なイブプロフェン注射製剤用組成物
CN109223764B (zh) Dmxaa在制备降血糖药物中的应用
CN112773799B (zh) 非索非那定用于制备治疗急性肺损伤的药物的用途
Ehret Aripiprazole Monohydrate (Abilify Asimtufii®): Second-Generation Antipsychotic Long-Acting Injectable
Walsh et al. A pediatric case study of treprostinil overdose
NZ767902B2 (en) Methods of treating ulcerative colitis
RU2021139235A (ru) Способы лечения дефицита альфа-1-антитрипсина (aatd)
BR122025017079A2 (pt) Combinação de dose fixa de cagrilintida e semaglutida e uso terapêutico e profilático da mesma
JP2016503406A5 (enExample)
Chan Intramuscular and Subcutaneous Administration
NZ767902A (en) Methods of treating ulcerative colitis
BR122024001315A2 (pt) Composições de agonista de gip/glp1